UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...

Researchers discovered an antioxidant, glutathione, that cancer cells appear to be "addicted to" as fuel, opening new ...

Developing the system required careful fine-tuning. Too much stimulation can wear out immune cells, while too little allows them to lose function. The researchers optimized the strength of activation ...

Some cancer cells don't die; they go quiet, like seeds lying dormant in the soil. These "sleeper cells," scattered throughout the body, can stay inactive for years. But when the body faces a ...

HeLa cells are the most famous human cells in science. Discover how cervical cancer, HPV proteins, and bioethics shaped one of medicine’s biggest breakthroughs.

A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500, is a "masked T-cell engager." This type of immunotherapy ignites our own ...

Finding an effective treatment for osteosarcoma, the most common type of bone cancer in children and young adults, has ...

Small cell lung cancer (SCLC) is a fast-growing cancer that forms in the lung. It's one of two types of lung cancer. The other type is non-small cell lung cancer (NSCLC). SCLC is less common than ...